Olympus Corporation et al.

Olympus Corporation (common short name: Olympus; TSE Prime: 7733) is a Japanese medical-technology company founded October 12, 1919, headquartered in Hachioji, Tokyo, with U.S. operations through Olympus America Inc. (Center Valley, Pennsylvania). It is publicly listed and has no parent owner. For the fiscal year ended March 31, 2026, Olympus reported consolidated revenue of ¥1,010.7 billion (roughly US$6.5–6.7 billion) and 28,138 consolidated employees, per its own company outline.

Operations. Olympus is a medical device maker concentrated in gastrointestinal endoscopy and surgical intervention. Its two reporting divisions are Gastrointestinal Solutions (GIS — digestive endoscopes, endoscopic ultrasound, endoscopy systems and repair services) and Surgical & Interventional Solutions (SIS — rigid/surgical endoscopes and therapeutic devices for urology, respiratory and GI procedures). The company has been narrowing its portfolio: it divested its camera/audio Imaging business to Japan Industrial Partners in 2021 (now OM Digital Solutions) and spun off its Scientific Solutions microscopes and industrial inspection business as Evident Corporation, which was sold to Bain Capital, closing in April 2023 for approximately ¥427.6 billion.

Litigation posture. Olympus is an operating company, not a patent assertion entity. The tracked data show it with one case as plaintiff and none as defendant, all in the U.S. District Court for the District of Delaware — not a plaintiff-friendly NPE venue such as the Eastern District of Texas. Its single tracked appearance, Olympus Corporation et al. v. Maxell, Ltd. (1:18-cv-00216, filed February 6, 2018), was a declaratory-judgment action brought by Olympus and Olympus America concerning Olympus digital camera products; Maxell counterclaimed for infringement of multiple patents.

Notable context. The dispute centered on the former Imaging business (accused models included the OM-D E-M1 Mark II, Pen-F, Tough TG-4 and Air A01) and on Maxell's U.S. Patent No. 8,478,102 on a recording/playback apparatus. In a November 14, 2018 ruling, the Delaware court denied Olympus's motion for judgment on the pleadings that the '102 patent was ineligible under 35 U.S.C. § 101. A related case, Maxell, Ltd. v. Olympus Corporation et al. (1:18-cv-00310), was filed in the same court days later; that case is not among the tracked appearances above. The patents at issue relate to a business Olympus has since divested.